Jun 2026 (Q2 FY26) — Aug 18, 2026
uCloudlink Q2 FY26 — Strategic Shift Towards uCloudlink 2.0 and New Business Lines
Read the full calluCloudlink earnings: last reported Tue, 18 Aug 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 0.00 | +265.2% YoY | Quarterly, as filed | Quarter to Mar 2026 | Revenue from operations as filed. |
| Operating margin | 0.9 | −8.1 pts YoY | Operating profit / revenue | Quarter to Mar 2026 | For the quarter; a change is in percentage points. |
| Net profit | -0.00 | Quarterly, as filed | Quarter to Mar 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
1Y: $2.18 on 17 Oct 2025 → $0.23. High $2.44 (19 Nov 2025), low $0.23 (14 Oct 2026).
Overview
Call summaries
uCloudlink Q2 FY26 — Strategic Shift Towards uCloudlink 2.0 and New Business Lines
Read the full callEvery analysed call
Financials
Net profit, year on year: +67% (quarter to mar 2026 against mar 2025).
| Line item | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating profit | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating margin | 2.9% | −4.9% | 3.5% | 3.5% | 1.5% | 9.0% | −0.7% | 0.9% |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | -0 | -0 | -0 | -0 | -0 | 0 |
| Tax rate | −71.0% | −2.0% | 109.0% | 36.0% | 10.0% | 9.0% | 17.0% | 215.0% |
| Net profit | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EPS ($ per share) | -0.04 | 0.94 | -1.44 | -1.23 | -1.01 | -0.46 | -1.89 | 1.38 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | — | 0 | — | 0 | 0 | — | — | — |
| Reserves | — | -100 | -163 | -210 | -229 | -227 | -222 | -216 |
| Total liabilities | — | 48 | 41 | 47 | 37 | 41 | 43 | 39 |
| Fixed assets | — | 4 | 3 | 2 | 1 | 2 | 4 | 2 |
| Investments | — | — | 0 | 13 | 0 | — | — | — |
| Total assets | — | 90 | 97 | 67 | 46 | 57 | 65 | 68 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -19 | 6 | -2 | -22 | 4 | 7 | 9 | 3 |
| Cash from investing | -5 | -3 | -35 | -1 | -0 | -0 | -4 | -1 |
| Cash from financing | 4 | 2 | 27 | 1 | 4 | 3 | 2 | 0 |
| Net cash flow | -20 | 4 | -11 | -22 | 8 | — | — | — |
| Capital expenditure | -5 | -3 | -1 | -1 | -0 | -2 | -4 | -1 |
| Free cash flow | -24 | 3 | -3 | -23 | 4 | 4 | 5 | 2 |
8 filings between Jun 4, 2026 and Aug 31, 2026.
Purchases
$10.9K
1 purchase by 1 insider
Sales
None
No insider sold shares.
Also filed: 1 code l.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Peng Zhiping | $10.9K | — | Jun 5, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 31, 2026 | Kong Ying Director | Award | 40,000 | $0 |
| Aug 31, 2026 | Ni Hope Director | Award | 40,000 | $0 |
| Aug 31, 2026 | Chen Chaohui Chief Executive Officer | Award | 1,000,000 | $0 |
| Aug 31, 2026 | Shi Yimeng Chief Financial Officer | Award | 500,000 | $0 |
| Aug 31, 2026 | Peng Zhiping Director | Award | 890,000 | $0 |
| Aug 31, 2026 | Gong Zhihui Chief Technology Officer | Award | 180,000 | $0 |
| Jun 5, 2026 | Peng Zhiping Director | Purchase | 10,000 | $10.9K |
| Jun 4, 2026 | Peng Zhiping Director | Code L | 10,000 | $10.0K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow uCloudlink Group Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading